Cargando…
Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
Background and Objectives: Tadalafil for treatment of fetal growth restriction (FGR) or preeclampsia is given once a day orally. The drug kinetics of tadalafil were investigated to determine the ideal dosage to promote uterine blood flow. Materials and Methods: We recruited five pregnant women with...
Autores principales: | Tanaka, Hiroaki, Maki, Shintaro, Magawa, Shoichi, Nii, Masafumi, Tanaka, Kayo, Ikemura, Kenji, Toriyabe, Kuniaki, Ikeda, Tomoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843393/ https://www.ncbi.nlm.nih.gov/pubmed/31640235 http://dx.doi.org/10.3390/medicina55100708 |
Ejemplares similares
-
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
por: Tsuchiya, Kyoka, et al.
Publicado: (2020) -
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring
por: Kawamura, Takuya, et al.
Publicado: (2021) -
Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction
por: Tsuji, Makoto, et al.
Publicado: (2023) -
Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial
por: Maki, Shintaro, et al.
Publicado: (2019) -
Evaluation of fetal acidemia during delivery using the conventional 5-tier classification and Rainbow systems
por: Magawa, Shoichi, et al.
Publicado: (2023)